Literature DB >> 6339464

beta-Lactamase inhibitors in perspective.

K Bush, R B Sykes.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6339464     DOI: 10.1093/jac/11.2.97

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment.

Authors:  B Giwercman; C Meyer; P A Lambert; C Reinert; N Høiby
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 2.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 3.  Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.

Authors:  J F Acar; L Gutmann; M D Kitzis
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Methodology for the study of beta-lactamases.

Authors:  K Bush; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

5.  Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.

Authors:  C C Sanders; J P Iaconis; G P Bodey; G Samonis
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 6.  Sulbactam/ampicillin in the treatment of lower respiratory infections.

Authors:  M A Castellano
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 7.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

8.  Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.

Authors:  M F Güneren
Journal:  Drugs       Date:  1988       Impact factor: 9.546

9.  Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora.

Authors:  A Iravani; G A Richard
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

10.  Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteria.

Authors:  M Hedberg; L Lindqvist; K Tunér; C E Nord
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.